We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleIOM urges FDA to be more aggressive in monitoring safety of approved drugs.AuthorsKuehn BMPublicationJAMA, 2012, Vol 307, Issue 23, p2475ISSN1538-3598Publication typearticleDOI10.1001/jama.2012.5993